Prescription drugs
Subtitle: implications of drug labeling and off-label use : statement of Sarah F. Jagger, Director of Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives
By: United States General Accounting Office
Contributors: United States. General Accounting Office; United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations
Series: Testimony -- GAO/T-HEHS-96-212; Testimony -- GAO/T-HEHS-96-212.
Publisher: The Office; The Office [distributor]
Published: 1996
Place of publication: Washington, D.C; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015)
Language: eng
Subjects: Drugs; Labeling; Prescribing; Generic substitution; Generic drugs
Other titles: Implications of drug labeling and off-label use
Notes: Not distributed to depository libraries in a physical form.

"September 12, 1996."

Includes bibliographical references.

Available via Internet from the GPO Access web site. Address as of 5/21/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he96212t.pdf; current access is available via PURL.